Protocol for covalent-targeted and activatable photoacoustic imaging agent for tumor imaging in mice

Jiho Song1, Tianqu Zhai2, Janggun Jo2

  • 1Department of Pharmacology and Chemical Biology, Emory University, Atlanta, GA 30322, USA.

STAR Protocols
|August 24, 2025
PubMed

Insights

This study introduces NOx-JS013, an activatable photoacoustic imaging probe that reduces background noise. This novel probe enables effective tumor imaging in aggressive prostate cancer mouse models.

Area of Science:

  • Biomedical imaging
  • Molecular imaging
  • Photoacoustic imaging

Background:

  • Endogenous chromophores create background noise in photoacoustic imaging.
  • Activatable probes can enhance signal specificity and reduce noise.
  • Developing targeted probes is crucial for accurate disease detection.

Purpose of the Study:

  • To present a protocol for a novel activatable covalent photoacoustic imaging probe, NOx-JS013.
  • To demonstrate the probe's utility in imaging aggressive prostate cancer in mouse models.
  • To establish a strategy for mitigating background noise in photoacoustic imaging.

Main Methods:

  • Synthesis of the activatable covalent photoacoustic imaging probe, NOx-JS013.
  • In vitro and in situ validation using gel-based activity-based protein profiling and cellular imaging.
  • Application of the probe for tumor imaging in aggressive prostate cancer mouse models.

Main Results:

  • Successful synthesis and characterization of the NOx-JS013 probe.
  • Demonstrated activity-based protein profiling and cellular uptake.
  • Effective visualization of tumors in aggressive prostate cancer mouse models using the probe.

Conclusions:

  • The NOx-JS013 probe is a viable tool for reducing background noise in photoacoustic imaging.
  • This activatable probe strategy facilitates enhanced tumor imaging in preclinical models.
  • The protocol provides a foundation for developing advanced photoacoustic imaging agents.

Related Concept Videos